American Well (AMWL) Stock Forecast, Price & News

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for American Well in the last twelve months. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AMWL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMWL, but not buy additional shares or sell existing shares.
View AMWL analyst ratings or view top-rated stocks.

7 brokerages have issued 1 year target prices for American Well's shares. Their AMWL share price forecasts range from $2.50 to $5.00. On average, they anticipate the company's stock price to reach $3.81 in the next year. This suggests a possible upside of 231.7% from the stock's current price.
View analysts price targets for AMWL or view top-rated stocks among Wall Street analysts.

American Well's stock was trading at $2.83 at the beginning of the year. Since then, AMWL shares have decreased by 59.4% and is now trading at $1.15.
View the best growth stocks for 2023 here.

American Well saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 9,550,000 shares, an increase of 12.2% from the August 15th total of 8,510,000 shares. Based on an average daily volume of 1,210,000 shares, the short-interest ratio is currently 7.9 days.
View American Well's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our AMWL earnings forecast.

American Well Co. (NYSE:AMWL) posted its quarterly earnings results on Wednesday, August, 2nd. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.02. The firm had revenue of $62.45 million for the quarter, compared to analysts' expectations of $65.45 million. American Well had a negative net margin of 226.24% and a negative trailing twelve-month return on equity of 29.76%.

ETFs with the largest weight of American Well (NYSE:AMWL) stock in their portfolio include Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

American Well updated its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $257.00 million-$263.00 million, compared to the consensus revenue estimate of $276.71 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other American Well investors own include PayPal (PYPL), NVIDIA (NVDA), Shopify (SHOP), Tesla (TSLA), Twilio (TWLO), Salesforce (CRM), Livongo Health (LVGO), Skyworks Solutions (SWKS), Slack Technologies (WORK) and Adobe (ADBE).

(AMWL) raised $525 million in an initial public offering (IPO) on Thursday, September 17th 2020. The company issued 35,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, Goldman Sachs, PIper Sandler, UBS Investment Bank, Credit Suisse, Cowen and Berenberg acted as the underwriters for the IPO.

American Well trades on the New York Stock Exchange (NYSE) under the ticker symbol "AMWL."

Shares of AMWL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMWL stock can currently be purchased for approximately $1.15.

American Well (NYSE:AMWL) has a market capitalization of $327.37 million and generates $277.19 million in revenue each year. The company earns $-270,430,000.00 in net income (profit) each year or ($2.22) on an earnings per share basis.

The company employs 1,035 workers across the globe.

American Well's mailing address is 75 STATE STREET 26TH FLOOR, Boston MA, 02109. The official website for the company is amwell.com. The company can be reached via phone at 617-204-3500 or via email at investors@amwell.com.